Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension

Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension

Luciana Neves Cosenso-Martin, Lais Yumi Takaoka, Jose Fernando Vilela-Martin Internal Medicine Division, State Medical School at Sao Jose do Rio Preto (FAMERP), Hospital de Base, Sao Jose do Rio Preto, Sao Paulo, BrazilCorrespondence: Jose Fernando Vilela-MartinState Medical School at Sao Jose do Ri...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cosenso-Martin LN, Takaoka LY, Vilela-Martin JF
Format: article
Langue:EN
Publié: Dove Medical Press 2020
Sujets:
type 2 diabetes
hypertension
glycemic variability
vascular endothelium
dipeptidyl-peptidase iv inhibitors
arterial stiffness
Specialties of internal medicine
RC581-951
Accès en ligne:https://doaj.org/article/b35bd148569741d0b3a3712e6c77151a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b35bd148569741d0b3a3712e6c77151a

Documents similaires